Dr. Barbara Yawn, Director of Research at Olmsted Medical Center in Rochester, MN, and one of the Study Coordinator for the Rochester Epidemiology Project, reviews her article appearing in the June 2013 issue of Mayo Clinic Proceedings, covering an overall 9% Herpes Zoster eye complication rate in that population between 1980 and 2011 of which about 6% resulted in permanent vision loss. Available at: http://tinyurl.com/cbkjj4a

Jessica Leung, an Epidemiologist at the Centers for Disease Control and Prevention in Atlanta, GA, discusses an article appearing in the October 2012 issue of Mayo Clinic Proceedings and describes chronic conditions as risk factors for herpes zoster, noting that new hypotheses and studies are needed to understand causes of herpes zoster and increasing incidence. Available at: http://www.mayoclinicproceedings.org/article/S0025-6196(12)00739-2/fulltext Visit the Mayo Clinic Proceedings...

Dr. Barbara Yawn, full-time clinical researcher and director of the Department of Research at Olmsted Medical Center, Rochester, MN, discusses her article appearing in Mayo Clinic Proceedings February 2011 issue (Available at: http://tinyurl.com/4seg89h ) on the recurrence of Herpes Zoster.

Dr. Barbara Yawn, Director of Research at Olmsted Medical Center, provides an overview of her study (http://tinyurl.com/mbnww3) on Health Care Utilization and the Cost Burden of Herpes Zoster, published in the September 2009 issue of Mayo Clinic Proceedings (www.mayoclinicproceedings.com).

http://www.biogetica.com - Biogetica has a groundbreaking approach to treating herpes that works in numerous ingenius ways to outsmart the virus. Nosodes are energetic imprints of a virus that are used to remind the immune system of exact viral RNA. Nosodes are used in a vaccine like manner to remind the immune system to create specific antibodies and fight the herpes virus even when it lies dormant. Nosodes fared brilliantly in independant clinic trials and helped 82% of genital herpes...